You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chemo-immunotherapy

Showing 1 - 25 of 4,252
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Split-course hypo-CCRT, Induction chemo-immunotherapy, Concurrent chemo)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Split-course hypo-CCRT
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Aug 26, 2023

Pancreatic Cancer Trial in Sydney, Wollongong, Melbourne (Durvalumab, Oxaliplatin, Irinotecan)

Recruiting
  • Pancreatic Cancer
  • Sydney, New South Wales, Australia
  • +2 more
Oct 19, 2023

Triple Negative Breast Tumors Trial (Pembrolizumab injection, Capecitabine tablets, Local radiotherapy)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • Pembrolizumab injection
  • +2 more
  • (no location specified)
Jul 25, 2023

Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant

Not yet recruiting
  • Breast Cancer Triple Negative
  • +3 more
    • Atlanta, Georgia
      Emory University/Winship Cancer Institute
    May 18, 2023

    Merkel Cell Carcinoma Trial in Milan (Retifanlimab, Cisplatin, Etoposide)

    Recruiting
    • Merkel Cell Carcinoma
    • Milan, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
    Jan 4, 2023

    Pleural Mesothelioma Trial in Italy (Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab)

    Not yet recruiting
    • Pleural Mesothelioma
    • Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab
    • Rozzano, MI, Italy
    • +5 more
    Nov 30, 2023

    Lung Cancer, Non-small Cell Trial in Nanjing (hypofractionated radiation therapy)

    Active, not recruiting
    • Lung Cancer, Non-small Cell
    • hypofractionated radiation therapy
    • Nanjing, Jiangsu, China
      Jiangsu Cancer Hospital
    Mar 13, 2023

    Ependymoma, Medulloblastoma, Glioblastoma Trial in Augusta (Ibrutinib, Indoximod, Cyclophosphamide)

    Recruiting
    • Ependymoma
    • +3 more
    • Augusta, Georgia
      Augusta University, Georgia Cancer Center
    Dec 16, 2022

    Small-cell Lung Cancer Trial in Shanghai (thoracic radiotherapy)

    Recruiting
    • Small-cell Lung Cancer
    • thoracic radiotherapy
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai jiaotong univestigy school of medicine
    Sep 21, 2022

    NSCLC Stage III Trial in Shanghai (standar thoracic RT dose, decreased thoracic RT dose)

    Recruiting
    • Non-small Cell Lung Cancer Stage III
    • standar thoracic RT dose
    • decreased thoracic RT dose
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai jiaotong univestigy school of medicine
    Sep 27, 2022

    Nonsmall Cell Lung Cancer, Performance Status Trial in Winston-Salem (Pembrolizumab, Carboplatin, Paclitaxel)

    Recruiting
    • Nonsmall Cell Lung Cancer
    • Performance Status
    • Winston-Salem, North Carolina
      Wake Forest Baptist Comprehensive Cancer Center
    Dec 19, 2022

    Head Neck Cancer, Metastatic Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Winston-Salem (Pembrolizumab,

    Recruiting
    • Head Neck Cancer
    • +5 more
    • Winston-Salem, North Carolina
      Wake Forest Baptist Health Sciences
    Aug 8, 2022

    Gastric Cancer Trial in Xi'an (dietary supplement, biological, drug)

    Recruiting
    • Gastric Cancer
    • Taurine
    • +3 more
    • Xi'an, Shaanxi, China
      Tang-Du Hospital
    Nov 7, 2023

    Ovarian Cancer Recurrent Trial in Pittsburgh (Rintatolimod, Pembrolizumab, Cisplatin)

    Recruiting
    • Ovarian Cancer Recurrent
    • Pittsburgh, Pennsylvania
      Magee-Womens Hospital of UPMC
    Mar 3, 2022

    NSCLC Trial in Indianapolis (Fasting-Mimicking Diet)

    Completed
    • Non-small Cell Lung Cancer
    • Fasting-Mimicking Diet
    • Indianapolis, Indiana
    • +2 more
    May 10, 2022

    Extensive Stage Small Cell Lung Cancer Trial in Chicago, Indianapolis, Iowa City (Cisplatin, Carboplatin, Etoposide)

    Recruiting
    • Extensive Stage Small Cell Lung Cancer
    • Chicago, Illinois
    • +2 more
    Jul 1, 2022

    NSCLC, Stage III Trial in Pavia (Durvalumab)

    Recruiting
    • NSCLC, Stage III
    • Pavia, Italy
      Fondazione IRCCS Policlinico San Matteo
    Nov 9, 2021

    Bladder Cancer Trial in Switzerland (Recombinant intravesical BCG (Bacillus Calmette-Guérin VPM1002BC), Atezolizumab, Cisplatin)

    Recruiting
    • Bladder Cancer
    • Recombinant intravesical BCG (Bacillus Calmette-Guérin VPM1002BC)
    • +3 more
    • Baden, Switzerland
    • +9 more
    Aug 12, 2022

    NSCLC Metastatic Trial in Salt Lake City (Durvalumab, Pemetrexed, Carboplatin)

    Recruiting
    • Non-Small Cell Lung Cancer Metastatic
    • Salt Lake City, Utah
      Huntsman Cancer Institute at University of Utah
    Mar 1, 2022

    NSCLC Trial in Guangzhou (Hypofractionated radiotherapy, induction chemo-immunotherapy, concurrent chemo)

    Recruiting
    • Non-small Cell Lung Cancer
    • Hypofractionated radiotherapy
    • +4 more
    • Guangzhou, Guangdong, China
      Sun yat-sen university cancer center
    Nov 14, 2023

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial

    Not yet recruiting
    • Anatomic Stage I Breast Cancer AJCC v8
    • +4 more
    • Biospecimen Collection
    • +9 more
    • (no location specified)
    Jun 26, 2023

    Cervical Cancer = FIGO IIB and or Lymph Node Metastases Trial (Pre-Chemo-radio-immunotherapy Treatment (Nivolumab/Ipilimumab),

    Not yet recruiting
    • Cervical Cancer ≥ FIGO IIB and or Lymph Node Metastases
    • Pre-Chemo-radio-immunotherapy Treatment (Nivolumab/Ipilimumab)
    • +2 more
    • (no location specified)
    Aug 16, 2022

    HIV, Burkitt's Lymphoma Trial in Italy (Induction Phase, Consolidation Phase (on day +50), Intensification phase)

    Completed
    • HIV
    • Burkitt's Lymphoma
    • Induction Phase
    • +4 more
    • Aviano (PN), Italy
    • +7 more
    Aug 2, 2022

    Small-cell Lung Cancer Trial in New York (Carboplatin, Etoposide, Atezolizumab)

    Recruiting
    • Small-cell Lung Cancer
    • New York, New York
      Columbia University Irving Medical Center, Herbert Irving Compre
    Apr 7, 2022

    Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8 Trial (drug, procedure,

    Not yet recruiting
    • Advanced Lung Non-Small Cell Carcinoma
    • +3 more
    • (no location specified)
    Oct 21, 2023